ECSP992970A - Secuencia del gen relacionado con angiopoyetino scarface 3 - Google Patents

Secuencia del gen relacionado con angiopoyetino scarface 3

Info

Publication number
ECSP992970A
ECSP992970A ECSP992970A ECSP992970A EC SP992970 A ECSP992970 A EC SP992970A EC SP992970 A ECSP992970 A EC SP992970A EC SP992970 A ECSP992970 A EC SP992970A
Authority
EC
Ecuador
Prior art keywords
scarface
proteins
angiopoyetino
sequence
gene related
Prior art date
Application number
Other languages
English (en)
Inventor
Paul Robert Rosteck
Stanley Gene Burgett
Josef Georg Heuer
Rebecca Ann Leonard
Patanjali Raghavac Sankhavaram
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP992970 priority Critical patent/ECSP992970A/es
Publication of ECSP992970A publication Critical patent/ECSP992970A/es

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención proporciona compuestos de ácido nucleico, de scarface 3, sus proteínas y fragmentos aislados, estando dichas proteínas Scarface 3 relacionadas con la familia de la angiopoyetina. También se proporcionan vectores y células huésped heterólogas transformadas para expresar Scarface 3, procedimientos para la identificación de compuestos que se unen a, y/o modulan la actividad de, dichas proteínas Scarface 3, además de procedimientos para tratar cáncer y la mielosupresión, y composiciones farmacéuticas que comprenden Scarface 3 o sus análogos.
ECSP992970 1999-06-01 1999-06-01 Secuencia del gen relacionado con angiopoyetino scarface 3 ECSP992970A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP992970 ECSP992970A (es) 1999-06-01 1999-06-01 Secuencia del gen relacionado con angiopoyetino scarface 3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP992970 ECSP992970A (es) 1999-06-01 1999-06-01 Secuencia del gen relacionado con angiopoyetino scarface 3

Publications (1)

Publication Number Publication Date
ECSP992970A true ECSP992970A (es) 2000-01-27

Family

ID=42043959

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP992970 ECSP992970A (es) 1999-06-01 1999-06-01 Secuencia del gen relacionado con angiopoyetino scarface 3

Country Status (1)

Country Link
EC (1) ECSP992970A (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9695233B2 (en) 2012-07-13 2017-07-04 Roche Glycart Ag Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
US12503503B2 (en) 2018-10-29 2025-12-23 Hoffmann-La Roche Inc. Bispecific anti-VEGF/ANG2 antibody formulation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9695233B2 (en) 2012-07-13 2017-07-04 Roche Glycart Ag Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
US12503503B2 (en) 2018-10-29 2025-12-23 Hoffmann-La Roche Inc. Bispecific anti-VEGF/ANG2 antibody formulation

Similar Documents

Publication Publication Date Title
BR112021012665A2 (pt) Polipeptídeos úteis para edição de genes e métodos de uso
BR112021022874A2 (pt) Proteínas de ligação epcam e métodos de uso
BR9711795A (pt) Peptìdeos tendo propriedades antiproliferativas
MX2020009514A (es) Anticuerpos anti-claudina 18.2 (cldn18.2).
AR053063A2 (es) Proteina sustancialmente purificada y composicion farmaceutica que la comprende
BR0316435A (pt) Produtos genéticos expressos diferencialmente em tumores e uso dos mesmos
ES2155702T3 (es) Construcciones expresivas halteroformes para la terapia genetica.
EP1103564A4 (en) CANCER ANTIGEN, BASED ON TUMOR SUPPRESSIVE GENEVA PRODUCT WT1
DK0556345T3 (da) Retrovirale vektorer,som er egnede til genterapi
BR112022012327A2 (pt) Anticorpos ou fragmentos dos mesmos, ácido nucleico, vetor e célula hospedeira
TR199902053T2 (xx) Prostat kanserinin immunoterapisine y�nelik bile�ikler ve bunlar�n kullan�lmas�na matuf metodlar.
DK1641818T3 (da) Polypeptider der har bindingsaffinitet for HER2
EP1005540A4 (en) IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS
ATE300619T1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
DE60142519D1 (de) Dna-expressionsvektoren
SA521422323B1 (ar) Ii معززات هجين واستخداماتها في العلاج، ولا سيما في علاج الأمراض المرتبطة بالكولاجين من النوع
DE60127715D1 (de) Polypeptide zur auslösung einer immunreaktion gegen krebs
EP0962530A3 (en) Gene sequence encoding for the angiopoietin related protein scarface 1
ECSP992970A (es) Secuencia del gen relacionado con angiopoyetino scarface 3
BR9712575A (pt) Processo para restaurar em células que apresentam uma proteìna p53 que sofreu mutação , uma atividade de transactivação p53-dependente, utilizações de um anticorpo de cadeia simples capaz de ligar especificamente uma proteìna p53 que sofreu mutação, e de um ácido nucleico codificante, molécula 11d3 ou uma variante, ácido nucleico e composição
SV1999000069A (es) Angiopoyetina relacionada con secuencia del gen 3 en la cicatrizacion de la cara ref. x-12261
BR112023022367A2 (pt) Anticorpos anti-tigit e métodos de uso dos mesmos
WO2022236276A3 (en) Anti-tigit antibodies, anti-cd96 antibodies, and methods of use thereof
SE0301987D0 (sv) New polypeptide
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen